Volume 20, Number 7—July 2014
Research
Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone
Table 4
Sample no. | ELISA |
PRNT |
||||
---|---|---|---|---|---|---|
IgM | IgG | EBOV | SUDV | TAFV | ||
060–1 | 0.35 | 0.00 | 40 | <10 | <10 | |
076–1 | 0.45 | 0.00 | 40 | <10 | 10 | |
085–1 | 0.20 | 0.00 | 40 | <10 | <10 | |
090–1 | 0.26 | 0.06 | 40 | <10 | <10 | |
118–2 | 0.23 | 0.00 | 40 | <10 | <10 | |
119–1 | 0.24 | 0.06 | <10 | <10 | <10 | |
120–1 | 0.38 | 0.00 | <10 | <10 | 10 | |
121–1 | 0.58 | 0.00 | <10 | <10 | <10 | |
122–1 | 0.66 | 0.00 | 40 | <10 | <10 | |
125–1 | 0.24 | 0.00 | ND | ND | ND | |
129–2 | 0.37 | 0.00 | <10 | <10 | <10 | |
130–1 | 0.40 | 0.03 | <10 | 40 | <10 | |
131–1 | 0.25 | 0.00 | <10 | <10 | <10 | |
132–1 | 0.21 | 0.09 | ND | ND | ND | |
143–1 | 0.30 | 0.00 | ND | ND | ND | |
144–1 | 0.35 | 0.06 | 40 | <10 | <10 | |
182–1 | 0.38 | 0.00 | ND | ND | ND | |
261–1 | 0.29 | 0.00 | 10 | <10 | <10 |
*Patient samples were tested for IgM and IgG reactivity in an EBOV ELISA. Samples with IgM only were tested for their ability to neutralize specific ebolaviruses, PRNT, plaque-reduction neutralization test; EBOV, Ebola virus; SUDV, Sudan Gulu strain; TAFV, Taï Forest (Cȏte d’Ivoire) viruses.
Page created: June 17, 2014
Page updated: June 17, 2014
Page reviewed: June 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.